Abstract: In devices that determine levels of substance use, a substance level in a test sample provided to the testing device by a test subject is determined. A sequence of images are captured to include a portion of the face of the test subject providing the test sample and a display of the testing device. A value indicative of the substance level detected within the test sample is determined. A validity indicator indicating validity of the value indicative of the substance level is determined. A current location is determined. The value indicative of the substance level, the validity indicator, and the current location are sent to a remote server.
Type:
Grant
Filed:
April 9, 2019
Date of Patent:
December 14, 2021
Assignee:
Robert F. Nienhouse 1997 Declaration of Trust
Abstract: In devices that determine levels of substance use, a substance level in a test sample provided to the testing device by a test subject is determined. A sequence of images are captured to include a portion of the face of the test subject providing the test sample and a display of the testing device. A value indicative of the substance level detected within the test sample is determined. A validity indicator indicating validity of the value indicative of the substance level is determined. A current location is determined. The value indicative of the substance level, the validity indicator, and the current location are sent to a remote server.
Type:
Grant
Filed:
November 4, 2019
Date of Patent:
March 23, 2021
Assignee:
Robert F. Nienhouse 1997 Declaration of Trust
Abstract: Levels of substance use, location, and vital signs are remotely monitored for a subject. In one embodiment, the system includes a testing device and a communication device. The testing device obtains a breathalyzer sample from a test subject and determines a substance level. The communication device reports the substance level to a remote monitoring station. In addition, location and camera functions of the communication device can report additional information for verification and system integrity. In other embodiments, the system can be incorporated into an ankle bracelet for monitoring movement of an individual or into a vehicle system to prevent operation while impaired.
Type:
Grant
Filed:
January 3, 2019
Date of Patent:
August 25, 2020
Assignee:
Robert F. Nienhouse 1997 Declaration of Trust
Abstract: In devices that determine levels of substance use, a substance level in a test sample provided to the testing device by a test subject is determined. A sequence of images are captured to include a portion of the face of the test subject providing the test sample and a display of the testing device. A value indicative of the substance level detected within the test sample is determined. A validity indicator indicating validity of the value indicative of the substance level is determined. A current location is determined. The value indicative of the substance level, the validity indicator, and the current location are sent to a remote server.
Type:
Grant
Filed:
December 29, 2016
Date of Patent:
November 5, 2019
Assignee:
ROBERT F. NIENHOUSE 1997 DECLARATION OF TRUST
Abstract: Levels of substance use, location, and vital signs are remotely monitored for a subject. In one embodiment, the system includes a testing device and a communication device. The testing device obtains a breathalyzer sample from a test subject and determines a substance level. The communication device reports the substance level to a remote monitoring station. In addition, location and camera functions of the communication device can report additional information for verification and system integrity. In other embodiments, the system can be incorporated into an ankle bracelet for monitoring movement of an individual or into a vehicle system to prevent operation while impaired.
Type:
Grant
Filed:
July 17, 2017
Date of Patent:
January 8, 2019
Assignee:
Robert F. Nienhouse 1997 Declaration of Trust
Abstract: Levels of substance use, location, and vital signs are remotely monitored for a subject. In one embodiment, the system includes a testing device (102) and a communication device (130). The testing device (102) obtains a breathalyzer sample from a test subject and determines a substance level. The communication device (130) reports the substance level to a remote monitoring station. In addition, location and camera functions of the communication device can report additional information for verification and system integrity. In other embodiments, the system can be incorporated into an ankle bracelet for monitoring movement of an individual or into a vehicle system to prevent operation while impaired.
Type:
Grant
Filed:
July 2, 2014
Date of Patent:
July 18, 2017
Assignee:
ROBERT F. NIENHOUSE 1997 DECLARATION OF TRUST